A glass of water immediately increases gastric pH in healthy subjects

Digestive Diseases and Sciences

Volumn 53, Issue 12, 2008, Pages 3128-3132

  Karamanolis, George ^a   Theofanidou, Ioanna ^a   Yiasemidou, Marina ^a   Giannoulis, Evangelos ^a   Triantafyllou, Konstantinos ^a   Ladas, Spiros D ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Gastric pH; Onset of action; PPIs; Ranitidine; Water antacids

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; ESOMEPRAZOLE; OMEPRAZOLE; RABEPRAZOLE; RANITIDINE; WATER;

ADULT; ARTICLE; CHRONOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUID INTAKE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MORNING DOSAGE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE DRUG DOSE; STOMACH JUICE; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTACIDS; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RANITIDINE; STOMACH; TIME FACTORS; WATER;

EID: 55949126896     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0301-3     Document Type: Article

References (18)

1. T Kennedy R Jones 2000 The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms Aliment Pharmacol Ther 14 1589 1589 10.1046/j.1365-2036.2000. 00884.x
2. BC Jacobson TG Ferris TL Shea 2003 Who is using chronic acid suppression therapy and why? Am J Gastroenterol 98 51 58 10.1111/j.1572-0241.2003.07186.x
3. R Fass MB Fennerty N Vakil 2001 Nonerosive reflux disease-current concepts and dilemmas Am J Gastroenterol 96 303 314
4. R Carlson J Dent 1998 Gastro-esophageal reflux disease (GORD) in primary care- an international study of different treatment strategies with omeprazole Eur J Gastroenterol Hepatol 10 119 124 10.1097/00042737-199802000-00004
5. GNJ Tytgat AL Blum M Verlinden 1995 Prognostic factors for relapse and maintenance treatment with cisapride in gastro-esophageal reflux disease Aliment Pharmacol Ther 9 271 280
6. KL Goh 2006 "On-demand" therapy for gastroesophageal reflux disease: are current proton pump inhibitors good candidates? J Gastroentrol Hepatol 21 Suppl 5 S115 S118 10.1111/j.1440-1746.2006.04714.x
7. JG Hatlebakk A Berstad 1996 Pharmacokinetic optimization in the treatment of gastro-oesophageal reflux disease Clin Pharmacokinet 31 386 406
8. NJ Bell D Burget CW Howden 1992 Appropriate acid suppression for management of gastro-oesophageal reflux disease Digestion 51 Suppl 1 59 67
9. S Hurlimann B Abbuhl W Inauen 1994 Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole Aliment Pharmacol Ther 8 193 201
10. JS Arnestad PM Klevemand HL Waldum 1997 In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity Aliment Pharmacol Ther 11 355 358 10.1046/j.1365-2036.1997.300000.x
11. M Inamori JI Towaga T Iwasaki 2005 Early effects of lafutidine or rabeprazole on intragastric acididty: which drug is more suitable for on-demand use? J Gastroenterol 40 453 458 10.1007/s00535-005-1569-0
12. Khoury RM, Katz PO, Castell DO (1999) Post-pradial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy subjects. Aliment Pharmacol Ther 1211-1214. doi: 10.1046/j.1365-2036.1999.00587.x
13. M Robinson 2001 New generation proton pump inhibitors: overcoming the limitations of early-generation agents Eur J Gastroenterol Hepatol 13 Suppl 1 S43 S47
14. H Hedenstrom C Alm M Kraft A Grahnen 1997 Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers Aliment Pharmacol Ther 11 1137 1141 10.1046/j.1365-2036.1997.00264.x
15. O Chassany JF Bergmann G Simoneau 1996 The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH Curr Ther Res 57 159 169 10.1016/S0011-393X(96)80121-4
16. Y Abe M Inamori J Togawa 2004 The comperative effects of single intravenous doses of omeprazole and famotidine on intragastric pH J Gastroenterol 39 21 25 10.1007/s00535-003-1286-5
17. D Pantoflickova G Dorta M Ravic 2003 Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors Aliment Pharmacol Ther 17 1507 1514 10.1046/j.1365-2036.2003.01496.x
18. J Zacny M Zamakhshary I Skertis S van Veldhuyzen Zanten 2005 Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients Aliment Pharmacol Ther 21 1299 1312 10.1111/j.1365-2036.2005. 02490.x